As of Dec 8, 2018 Alcentra Capital Corp (NASDAQ:ABDC) Shorts Declined By 18.16%

Change of 18.16% for Alcentra Capital Corp (NASDAQ:ABDC)’s shorted shares was recorded. In December was issued ABDC’s total 60,400 shorted shares by FINRA. That’s 18.16% down from 73,800 shares. Former ABDC’s position will need 2 days to restore. It has 40,300 average volume.

ABDC is touching $6.45 during the last trading session, after increased 0.62%.Alcentra Capital Corporation has volume of 29,864 shares. Since December 8, 2017 ABDC has declined 41.63% and is downtrending. The stock underperformed the S&P 500 by 57.25%.

Alcentra Capital Corporation is a business development firm specializing in investments in lower middle-market companies.The firm is worth $87.12 million. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and gas and oil services sector.Last it reported negative earnings. It focuses on investment opportunities headquartered in North America.

For more Alcentra Capital Corporation (NASDAQ:ABDC) news brought out recently go to: Seekingalpha.com, Nasdaq.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “This 11.2% Yielding BDC Is Ready For Shareholder Activism – Seeking Alpha” brought out on May 30, 2018, “New Research Coverage Highlights Alcentra Capital, VeriSign, Americold Realty Trust, Internet Initiative Japan, DAVIDsTEA, and Cidara Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018 – Nasdaq” on November 14, 2018, “Stable 9.5% Yield And Shareholder Approval To Increase Leverage – Seeking Alpha” with a publish date: August 01, 2018, “Alcentra Capital: Selling Stock Or Selling Out? – Seeking Alpha” and the last “9.3% Yield And Recent Rally From Rising Book Value – Seeking Alpha” with publication date: August 22, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.